Monthly Archives: August 2010
Statistics recently released by the International Society of Aesthetic Plastic Surgery offer insight into global plastic surgery trends, suggesting that despite economic troubles, consumer demand for body contouring and facial plastic surgery procedures, as well as injectable treatments, remained high … Continue reading
Xeomin, a botulinum type A injectable treatment made by German pharmaceutical giant Merz, was finally FDA-approved to join Botox and Dysport on the U.S. market in late September, after having been available in Europe since 2008. Xeomin will likely compete … Continue reading
